CVS Reverses Its Zepbound Decision — What It Means for GLP-1 Patients

CVS Caremark has announced a major update to its GLP-1 weight-loss medication coverage, expanding access to drugs like Zepbound (Eli Lilly) and continuing coverage for Wegovy (Novo Nordisk) across its standard commercial formularies. In this video, we break down what changed, when coverage updates take effect, and how these decisions may impact millions of Americans enrolled in employer-sponsored health plans. While CVS sets standard formulary options, individual insurance plans and employers still determine actual coverage, prior authorization requirements, and out-of-pocket costs. We also explain what “preferred formulary status” means, how GLP-1 medications are accessed through CVS Caremark, and what patients should know about eligibility and pricing. 👉 Topics covered: • CVS Caremark GLP-1 coverage update 2026 • Zepbound (tirzepatide) and Wegovy availability • What “preferred drug” status means • How employer insurance affects coverage • Estimated copays and access requirements • What patients should do next to check coverage 00:00 Introduction and what originally happened with the CVS Caremark Zepbound decision 01:56 CVS has reversed it's decision on Zepbound and copays may be dropping for insured patients 03:05 Why this formulary change matters to patients 04:42 What CVS's reversal says about GLP-1 access 05:51 The ever-changing landscape of GLP-1 access and final thoughts on where we are headed Looking for some of the products that have helped me on my GLP-1 journey? I've put together an Amazon storefront featuring many of my favorite protein and fiber snacks, hydration products, supplements, fitness gear, and everyday items that have supported me along the way. 👉 Browse my recommendations here: https://a.co/d/007yZySn As an Amazon Associate I earn from qualifying purchases. Disclaimer: This video is for informational purposes only and does not constitute medical or insurance advice. Always check with your insurance provider or healthcare professional for details about your specific plan. #cvscaremark #cvs #zepbound #wegovy #glp1

Why I'm Going Back to Zepbound After Trying Multiple Compounded Tirzepatide Pharmacies
▶︎

Why I'm Going Back to Zepbound After Trying Multiple Compounded Tirzepatide Pharmacies

How to Inject Tirzepatide To MAXIMIZE It's Effectiveness (Doctor Explains)
▶︎

How to Inject Tirzepatide To MAXIMIZE It's Effectiveness (Doctor Explains)

Medicare's New GLP-1 Rule: The BMI Surprise You Need to Know
▶︎

Medicare's New GLP-1 Rule: The BMI Surprise You Need to Know

🚨 CVS Caremark Finally Added Zepbound Back: Here's When You'll Get It
▶︎

🚨 CVS Caremark Finally Added Zepbound Back: Here's When You'll Get It

(Dr Explains) 8 Signs You're Taking Too Much Ozempic, Mounjaro, or Zepbound!
▶︎

(Dr Explains) 8 Signs You're Taking Too Much Ozempic, Mounjaro, or Zepbound!

These 10 Freezer Foods Are Different on GLP-1 | Here's Why
▶︎

These 10 Freezer Foods Are Different on GLP-1 | Here's Why

The GLP-1 Program Medicare Headlines Are Missing
▶︎

The GLP-1 Program Medicare Headlines Are Missing

Why Some People Don’t Lose Weight on GLP-1s | New Genetic Research Explained
▶︎

Why Some People Don’t Lose Weight on GLP-1s | New Genetic Research Explained

Tapering Off GLP-1s Like Wegovy & Zepbound: A Clinical Perspective
▶︎

Tapering Off GLP-1s Like Wegovy & Zepbound: A Clinical Perspective

5 Signs Your GLP-1 Is FAILING (Obesity Doctor Explains)
▶︎

5 Signs Your GLP-1 Is FAILING (Obesity Doctor Explains)

Medicare Will Now Cover Weight Loss Drugs for $50 — But There's a Catch
▶︎

Medicare Will Now Cover Weight Loss Drugs for $50 — But There's a Catch

I Switched to Compounded Tirzepatide
▶︎

I Switched to Compounded Tirzepatide

I'm a Pathologist. Ozempic & Mounjaro Aren't Actually Weight Loss Drugs.
▶︎

I'm a Pathologist. Ozempic & Mounjaro Aren't Actually Weight Loss Drugs.

How I Stay Hydrated on GLP-1s | Hydration Tips for Zepbound, Wegovy & Ozempic
▶︎

How I Stay Hydrated on GLP-1s | Hydration Tips for Zepbound, Wegovy & Ozempic

I Said I'd Never Take Mounjaro Again
▶︎

I Said I'd Never Take Mounjaro Again

New GLP-1 Cancer Research: Ozempic, Wegovy & Zepbound Linked to Lower Cancer Risk
▶︎

New GLP-1 Cancer Research: Ozempic, Wegovy & Zepbound Linked to Lower Cancer Risk

Smart Dining on GLP-1s: What to Order at Restaurants on Ozempic, Wegovy & Zepbound
▶︎

Smart Dining on GLP-1s: What to Order at Restaurants on Ozempic, Wegovy & Zepbound

GLP-1 News Roundup: 10 Massive Pharma Updates (Retatrutide, Foundayo, Zepbound & Wegovy)
▶︎

GLP-1 News Roundup: 10 Massive Pharma Updates (Retatrutide, Foundayo, Zepbound & Wegovy)

Ozempic & Mounjaro: Same Shot. Opposite Results.
▶︎

Ozempic & Mounjaro: Same Shot. Opposite Results.

I Lost 150+ lbs on Mounjaro — Here's How I Broke Through Every Weight Loss Plateau
▶︎

I Lost 150+ lbs on Mounjaro — Here's How I Broke Through Every Weight Loss Plateau